Patricia Françon

COO at Coave Therapeutics

Patricia has over 20 years of experience in the biotech industry-leading R&D, preclinical and clinical operations as well as manufacturing for the accelerated development of innovative biologics, including advanced cell & gene therapies. Patricia joined Coave from Skinosive where she served as Chief Operating/Technology Officer until November 2021. At Skinosive she managed all operational aspects of the business, proactively driving the company towards achieving its development goals.

Patricia obtained her PhD in Molecular and Cellular Biology from Paris VI University and completed her postdoctoral research at McGill University.

Links

Previous companies

Cellectis logo
Sartorius logo
Enterome logo
Sanofi logo
McGill University logo

Timeline

  • COO

    November, 2021 - present

View in org chart